| |
Latest 10 SEC filings (by transaction date) for KRYS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 11/24 | Mar 11/24 | Krishnan Suma | Indirect Ownership | Common Stock | S - Open market or private sale | -2,254 | $168.88 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Indirect Ownership | Common Stock | S - Open market or private sale | -2,146 | $167.99 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -800 | $174.13 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -3,587 | $173.30 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -2,800 | $172.21 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -5,469 | $171.09 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -8,040 | $170.42 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -1,646 | $168.96 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Indirect Ownership | Common Stock | S - Open market or private sale | -1,314 | $174.00 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Indirect Ownership | Common Stock | S - Open market or private sale | -3,359 | $173.09 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for KRYS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 11/24 | Mar 11/24 | Krishnan Suma | Indirect Ownership | Common Stock | S - Open market or private sale | -2,254 | $168.88 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Indirect Ownership | Common Stock | S - Open market or private sale | -2,146 | $167.99 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -800 | $174.13 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -3,587 | $173.30 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -2,800 | $172.21 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -5,469 | $171.09 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -8,040 | $170.42 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Direct Ownership | Common Stock | S - Open market or private sale | -1,646 | $168.96 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Indirect Ownership | Common Stock | S - Open market or private sale | -1,314 | $174.00 |
Mar 11/24 | Mar 11/24 | Krishnan Suma | Indirect Ownership | Common Stock | S - Open market or private sale | -3,359 | $173.09 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |